Entering text into the input field will update the search result below

Core Scientific trades high on preliminary 2021 and 2022 operating guidance

  • Core Scientific (CORZ +5.6%) sees prelim 2021 revenue to be in the range of $515 to $545M, net income of $50 to $60M and adj. EBITDA of $225 to $235M.
  • It expects total operating hashrate of 31 EH/s to 40-42

Recommended For You

About CORZ Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
CORZ--
Core Scientific, Inc.